Details for New Drug Application (NDA): 018757
✉ Email this page to a colleague
NDA 018757 describes CALCIBIND, which is a drug marketed by Mission Pharma and is included in one NDA. Additional details are available on the CALCIBIND profile page.
The generic ingredient in CALCIBIND is cellulose sodium phosphate. There are one hundred and fifty-seven drug master file entries for this compound. Additional details are available on the cellulose sodium phosphate profile page.
The generic ingredient in CALCIBIND is cellulose sodium phosphate. There are one hundred and fifty-seven drug master file entries for this compound. Additional details are available on the cellulose sodium phosphate profile page.
Summary for 018757
| Tradename: | CALCIBIND |
| Applicant: | Mission Pharma |
| Ingredient: | cellulose sodium phosphate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | 2.5GM/PACKET | ||||
| Approval Date: | Dec 28, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | 300GM/BOT | ||||
| Approval Date: | Oct 16, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
